Symptomatic hypocalcaemia after treatment with zoledronic acid in a patient with multiple myeloma [2]

Annals of Oncology

Volumn 15, Issue 12, 2004, Pages 1848-

  Singh, D ^a   Khaira, N S ^a   Sekhon, J S ^a  

^a DAYANAND MEDICAL COLLEGE AND HOSPITAL   (India)

Author keywords

[No Author keywords available]

Indexed keywords

CALCIUM; COLECALCIFEROL; GLUCONATE CALCIUM; MELPHALAN; PREDNISOLONE; ZOLEDRONIC ACID;

ADULT; BLOOD EXAMINATION; BONE MARROW EXAMINATION; BONE METASTASIS; CALCIUM BLOOD LEVEL; CASE REPORT; CLAVICLE; FEMALE; HUMAN; HYPOCALCEMIA; LETTER; LUMBAR SPINE; MULTIPLE MYELOMA; OSTEOLYSIS; PRIORITY JOURNAL; RIB; SCAPULA; SYMPTOMATOLOGY;

CALCIUM; DIPHOSPHONATES; FEMALE; HUMANS; HYPOCALCEMIA; IMIDAZOLES; MIDDLE AGED; MULTIPLE MYELOMA;

EID: 10944269168     PISSN: 09237534     EISSN: None     Source Type: Journal    
DOI: 10.1093/annonc/mdh479     Document Type: Letter

References (4)

1. Wellington K, Goa KL. Zoledronic acid: a review of its use in the management of bone metastasis and hypercalcaemia of malignancy. Drugs 2003; 63: 417-437.
2. Breen TL, Shane E. Prolonged hypocalcaemia after treatment with zoledronic acid in a patient with prostate cancer and vitamin D deficiency. J Clin Oncol 2004; 22: 1531-1532.
3. Body JJ, Lortholary A, Romieu G et al. A dose finding study of zole-dronate in hypercalcaemic cancer patients. J Bone Miner Res 1999; 14: 1557-1561.
4. Major PP, Coleman RE. Zoledronic acid in the treatment of hypercalcaemia of malignancy: Results of the international clinical development program. Semin Oncol 2001; 28: 17-24.